Back

Featured Topics

Behind The Science
Breast Cancer
Cancer Immunotherapy
Hematology
Lung Cancer
Manufacturing
Multiple Sclerosis
Oncology
Ophthalmology
Partnering
Respiratory Health
Rheumatology
About Us Contact Us Leadership Awards & Recognition Investors Suppliers Compliance
  • Twitter
  • Facebook
  • LinkedIn

The Lung Cancer Project


Read More Stories
Apr 5, 2016

Holli Kolkey*

Associate Director, Corporate Relations

*While Holli was an employee at the time this article was published, she has since left Genentech.


A few weeks after joining Genentech in 2011, I had the opportunity to meet with several lung cancer patient advocacy groups. I asked them what kept them up at night and I was shocked by their answer.

“About half of all people with lung cancer never get treated,” one of them said.

How can that be?

As I started to dig deeper into this question, I came across a few studies that referenced low treatment rates in lung cancer and hypothesized that stigma, shame and hopelessness may be factors. Lung cancer was seen as a smoker’s disease and it appeared there was an underlying blame that if you had lung cancer, you did it to yourself.

Is that true? Do we as a society really believe that? And even if we do, does that mean people with lung cancer don’t deserve our compassion and care?

Time for Answers and Action

In mid-2012, my colleagues and I brought together nearly 20 advocacy and industry organizations to form The Lung Cancer Project, a movement to identify, understand and remove stigma and other barriers faced by people with lung cancer – so everyone receives the care they deserve.

The first order of business was research. In order to change the way people think about lung cancer, we needed data. (We’re Genentech, that’s what we do.)

We conducted the first study to validate a hypothesis posed in several peer-reviewed studies that the majority of people associate lung cancer with stigma, shame, and hopelessness. To do this, we partnered with Project Implicit®, a network of scientists from Harvard University, the University of Virginia and the University of Washington who study subconscious attitudes.

The Lung Cancer Project’s website houses sharable content on the history and statistics of lung cancer, barriers to treatment, advances in care, as well as the Implicit Association Test, where readers can test their lung cancer bias.

When I saw the data, it broke my heart.

Most people in the study believed that a person was at least partially to blame for their lung cancer. Even more alarming, these beliefs were consistent across the general public, people with lung cancer, their caregivers and even healthcare providers.

I wasn’t sure what upset me more: people being denied hope or dealing with shame while fighting for their life. It reminded me of how people reacted to AIDS patients in the ‘80s.

With the evidence in our hands, it was time to start a dialogue about lung cancer stigma and raise awareness of the broader impact on people with the disease.

We first presented the data at the 2013 American Society of Clinical Oncology Annual Meeting, which is attended by 30,000 healthcare professionals. It was a very somber moment to hear the discussant reflect on the “sad” results (these results were recently published in the scientific journal PLOS ONE in December 2015).

Together, with patient advocates and the authors of the study, we leveraged those data to start a national dialogue about lung cancer stigma and bias. Through traditional and social media, we engaged millions of people, including patients, caregivers and healthcare providers, to address bias and change the way we think about lung cancer. Heather Millar, who writes for WebMD noted that even though she was she was knowledgeable enough to be unbiased “The online test I took suggests that, unconsciously, my ideas are different (Read her entire article here).”


We have expanded beyond stigma and have completed a total of six studies that found:

  • A negative stigma exists towards people with lung cancer.

  • Many demographic factors impact treatment rates.

  • One in four people with metastatic lung cancer never see an oncologist and one in 10 never get anti-cancer therapy.

  • One-year survival for people with advanced lung cancer has more than doubled from 1990 to 2015. That means even a 10% increase in people getting treated could add more than 35,000 years of life across the entire population.


Social Change

Society’s view of AIDS has come a long way in 30 years, people now know more about the disease, treatments have radically improved and stigma has been drastically reduced. Attitudes about lung cancer need to go through a similar evolution.

Now is the time for social change in how we view lung cancer, and we need your help:

  • Join the movement
  • Follow us on Twitter
  • Recommend research topics

Together we can help everyone get the care they deserve. We have a vision for change. And now is the time to make that change happen. `QED Mark`


Tags:

  • Lung Cancer

Read More Stories

Read about breakthrough science, the everyday people who make it happen, and the patients we serve.

?? of 40 moments published

  • Now Hiring
  • Find A Job
  • Professional Areas
  • Diversity & Inclusion
  • Chief Diversity Officer
  • Fostering Belonging
  • Advancing Inclusive Research & Health Equity
  • Transforming Society
  • Our 2021 Diversity & Inclusion Report
  • Our Work in Action
  • Kindergarten to Careers
  • For Scientists
  • Our Scientists
  • Publications
  • Oncology
  • Immunology
  • Neuroscience
  • Metabolism
  • Infectious Disease
  • Ophthalmology
  • For Patients
  • Our Medicines
  • Our Approach to Pricing
  • Patient Advocacy
  • Financial Support
  • Medicine Information Support
  • Create With Us
  • Clinical Trial Information
  • Genentech Patient Foundation
  • Disease Education
  • Advancing Inclusive Research
  • For Medical Professionals
  • Our Medicines & Products
  • Our Pipeline
  • Medical Resources
  • Clinical Trial Information
  • Sunshine Act Compliance
  • Product Security
  • For Partners
  • Our Approach
  • What We Are Looking For
  • Partner With Us
  • BIO 2022
  • Our Stories
  • For Media
  • News Features
  • Press Releases
  • Statements
  • Company Information
  • Sign Up For News Alerts
  • For Good
  • Giving
  • Diversity & Inclusion
  • Sustainability
  • About Us
  • Leadership
  • Policy & Advocacy
  • Our Focus on Oncology
  • Awards & Recognition
  • Investors
  • Suppliers
  • Our Approach to Pricing
  • CA Transparency in Supply
  • Compliance Overview
  • Contact Us
  • Call Us
  • Email Us
  • Visit us
  • Submit a Medical Inquiry
  • Submit a Media Inquiry
  • Privacy
  • Privacy Policy
  • Terms & Conditions
© 2022 Genentech, Inc. All rights reserved. This site is intended for US residents only.